Ischemic white matter disease (Binswanger's disease)

2016

Closed access Metadata (CSL-JSON)
DOI 10.1002/9781118777329.ch5
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Binswanger's disease is frequently characterized by recurrent transient ischemic attacks and small strokes, with reversible hemiparesis and pure motor weakness, uneven reflexes, akinesia, and other mild neurological deficits. In general, Binswanger's disease begins with mild confusion, apathy, personality changes, and memory loss. The diagnosis of Binswanger's disease is confirmed by magnetic resonance imaging (MRI) or computed tomography (CT) based on three findings: diffuse bilateral density reduction in the white matter, especially around the frontal horns of the lateral ventricles; multiple small cysts in the white matter; and expansion of the ventricle volume. The most severe and widespread changes are likely to be seen in patients with malignant hypertension presenting with frequent vascular crises. The most widely criteria for dementia in clinical practice are those proposed by the American Psychiatric Association (DSM IV). Treatment of Binswanger's disease should be directed at the underlying causes, primarily arterial hypertension.